CCL2: C-C Motif Chemokine Ligand 2
Key mediator of monocyte/macrophage recruitment and inflammation
Gene Information Card
| Symbol | CCL2 |
|---|---|
| Full Name | C-C Motif Chemokine Ligand 2 |
| Gene Type | protein-coding |
| Chromosomal Location | 17q12 |
| NCBI Gene ID | 6347 ncbi.nlm.nih.gov/gene/6347 |
| Ensembl ID | ENSG00000108691 |
| UniProt ID | P13500 |
| OMIM ID | 158105 |
| HGNC ID | 10618 |
| Aliases | MCP-1, MCAF, SCYA2, GDCF-2, HC11, SMC-CF |
Description
CCL2 (C-C Motif Chemokine Ligand 2), also known as monocyte chemoattractant protein-1 (MCP-1), is a chemokine that recruits monocytes, memory T cells, and dendritic cells to sites of inflammation. It signals through CCR2 and plays a central role in inflammatory diseases, atherosclerosis, and tumor progression.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Atherosclerosis | CCL2 recruits monocytes to arterial walls, promoting foam cell formation and plaque development | OMIM 158105; NCBI Gene |
| Rheumatoid Arthritis | Elevated CCL2 in synovial fluid attracts macrophages, driving joint inflammation | OMIM 158105; NCBI Gene |
| Multiple Sclerosis | CCL2/CCR2 axis mediates CNS infiltration of inflammatory cells | OMIM 158105; NCBI Gene |
| Cancer (breast, prostate, ovarian) | CCL2 promotes tumor-associated macrophage recruitment and metastasis | COSMIC; NCBI Gene |
| Diabetic Nephropathy | CCL2 overexpression in renal tissue correlates with macrophage infiltration and fibrosis | OMIM 158105; NCBI Gene |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Adipose tissue | 12.5 | Medium |
| Lung | 8.3 | Medium |
| Spleen | 15.1 | High |
| Liver | 6.7 | Low |
| Kidney | 9.2 | Medium |
| Heart | 4.1 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| THP-1 (monocyte) | 45.2 | High baseline; induced by LPS |
| HeLa (cervical carcinoma) | 3.8 | Low constitutive |
| A549 (lung carcinoma) | 7.1 | Inducible by IL-1β |
| MCF-7 (breast carcinoma) | 2.5 | Low |
| HUVEC (endothelial) | 22.0 | High; induced by TNF-α |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| rs1024611 (-2578A>G) | SNP (promoter) | Common (MAF ~0.45) | Increased CCL2 expression; associated with atherosclerosis risk |
| rs2857656 (-2136T>C) | SNP (promoter) | Common (MAF ~0.30) | Modulates transcription; linked to rheumatoid arthritis |
| c.275C>T (p.Ala92Val) | Missense | Rare | Unknown functional impact; reported in COSMIC |
Mutation functional classification
Loss of Function (LOF)
No well-characterized loss-of-function mutations reported in CCL2.
Gain of Function (GOF)
Promoter SNPs (e.g., rs1024611) increase transcription, leading to elevated CCL2 levels and enhanced inflammatory response.
Dominant Negative (DN)
Not described for CCL2.
View complete mutation data:
Gene Ontology (GO)
Pathways
• Chemokine signaling pathway (KEGG: hsa04062)
• Cytokine-cytokine receptor interaction (KEGG: hsa04060)
• Toll-like receptor signaling pathway (KEGG: hsa04620)
• NF-kappa B signaling pathway (KEGG: hsa04064)
• CCR2-mediated chemotaxis (Reactome: R-HSA-373076)
Protein Summary
CCL2 is a 99-amino-acid secreted chemokine (UniProt P13500) that forms a homodimer and binds to CCR2. It is produced by multiple cell types including monocytes, endothelial cells, and fibroblasts. The protein contains a conserved CC chemokine domain with four cysteine residues forming two disulfide bonds. Post-translational modifications include signal peptide cleavage (residues 1-23) and potential glycosylation. CCL2 is a key regulator of monocyte/macrophage trafficking and is implicated in chronic inflammation and cancer.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CCL21 Knockout HEK293 Cell Line | EDJ-KQ549 | Human | 6366 | Details Get a Quote |
| CCL20 Knockout HEK293 Cell Line | EDJ-KQ889 | Human | 6364 | Details Get a Quote |
| CCL2 Knockout HEK293 Cell Line | EDJ-KQ995 | Human | 6347 | Details Get a Quote |
| CCL25 Knockout HEK293 Cell Line | EDJ-KQ1472 | Human | 6370 | Details Get a Quote |
| CCL22 Knockout HEK293 Cell Line | EDJ-KQ2433 | Human | 6367 | Details Get a Quote |
| CCL23 Knockout HEK293 Cell Line | EDJ-KQ5732 | Human | 6368 | Details Get a Quote |
| CCL26 Knockout HEK293 Cell Line | EDJ-KQ7014 | Human | 10344 | Details Get a Quote |
| CCL24 Knockout HEK293 Cell Line | EDJ-KQ12818 | Human | 6369 | Details Get a Quote |
| CCL28 Knockout HEK293 Cell Line | EDJ-KQ12819 | Human | 56477 | Details Get a Quote |
| CCL2 Knockout A-549 Cell Line | EDJ-KQ20029 | Human | 6347 | Details Get a Quote |
| CCL20 Knockout A-549 Cell Line | EDJ-KQ21060 | Human | 6364 | Details Get a Quote |
| CCL28 Knockout HeLa Cell Line | EDJ-KQ41953 | Human | 56477 | Details Get a Quote |
| CCL2 Knockout HeLa Cell Line | EDJ-KQ18711 | Human | 6347 | Details Get a Quote |
| CCL26 Knockout A-549 Cell Line | EDJ-KQ31752 | Human | 10344 | Details Get a Quote |
| CCL27 Knockout HEK293 Cell Line | EDJ-KQ51011 | Human | 10850 | Details Get a Quote |
Displaying Records 1 To 15 Of 40 Records
- 1
- 2
- Next Page »